Two-year risedronate treatment for osteoporosis in patients with esophageal varices: a non-randomized clinical trial.

Lívia Alves Amaral SantosTalles Bazeia LimaHélio Rubens de Carvalho NunesXingshun QiFernando Gomes Romeiro

Published in: Hepatology international (2022)

Oral risedronate was effective and did not cause gastrointestinal bleeding in cirrhotic patients with esophageal varices under endoscopic surveillance.

Keyphrases

public health
postmenopausal women
ultrasound guided
bone mineral density
double blind
smoking cessation